Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape

Journal: Science Translational Medicine

Published: 2020-03-25

DOI: 10.1126/scitranslmed.aay8456

Affiliations: 2

Authors: 22

Go to article
Institutions Share
Scholar Rock, United States of America (USA) 0.95
Children's Hospital of Philadelphia (CHOP), United States of America (USA) 0.05